Please assess the completion status of the following clinical trial:

Trial Title: Cardiac Safety of Repeated Doses of Dihydroartemisinin-Piperaquine for the Use in Mass Treatment Campaigns

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~1. Male or female ≥3 years to ≤50 years~2. Good general health by medical history physical examination, baseline electrocardiographs and laboratory tests.~3. No clinically relevant abnormalities in blood pressure and heart rate~4. No clinically relevant abnormalities in 12-lead ECG results\*~   \*Patients with a QTcB or QTcF greater than 450 ms or clinically significant abnormalities of rhythm at Screening are not eligible. Patients with a pre-dose baseline value \> 450 ms should be withdrawn from the study prior to dosing.~   Exclusion Criteria:~5. A history of additional risk factors for Torsades-des-Pointes (e.g., heart failure, hypokalemia, family history of Long QT Syndrome);~6. The use of concomitant medications that prolong the QT/QTc interval;~7. Any condition requiring regular concomitant medication, including herbal products and over-the-counter (OTC) medication or predicted need of any concomitant medication during the study;~8. History of relevant clinical allergic reactions of any origin;~9. Any other condition that in the opinion of the Investigator would interfere with the evaluation of the results or constitute a health risk for the subject;~10. Patients who are not willing to give informed consent (patient and/or parent/legal representative), or who withdraw consent.~11. Pregnant women in the 1st trimester of pregnancy.

- Gender: ALL
- Minimum Age: 3 Years
- Maximum Age: 49 Years
- Healthy Volunteers: t

Study Arms:
- Dihydroartemisinin-piperaquine (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).